Short communication · Aug 2021
Conference abstractPublished 11 Aug 2016
Effect of Phoenix dactylifera palm date (Ajwa) on infection, hospitalization and mortality among pediatric cancer patients at single medical institute in Saudi Arabia
King Abdulaziz University Hospital, KSA; King Fahd Medical Research Center, KSA; Ministry of Health-Jeddah, KSA; The Pharmaceutical Research Institute-Albany, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Recent studies showed that Phoenix dactylifera palm date have good nutritious value and medicinal potential. The aim of the study was to determine the effect of regular intake of Phoenix dactylifera palm date called Ajwa on number of infections, hospitalization associated with fever neutropenia and mortality of pediatric cancer patients admitted to King Abdul-Aziz University Hospital, a tertiary care medical center, Faculty of Medicine, King Abdul-Aziz University, Jeddah, Kingdom of Saudi Arabia. Methods: A non-randomized controlled intervention study was done during the period of 2008-2015. A total of 55 pediatric cancer patients with hematologic or non-hematologic malignancies (who were treated by chemotherapy/radiotherapy) were enrolled in the study. A total of 32 patients were given Ajwa and 23 did not administer Ajwa. The outcomes were compared between both groups within the 5 years follow-up period. Culture and sensitivity was done. The study was approved by Ethics Research Committee of the hospital. Results: The study included 27 males and 28 females, with male to female ratio of almost 1:1. Their mean age was 9.3 with S.D. of Ã?± 4.4. Children enrolled in the Ajwa group showed minimal positive cultures as compared to non Ajwa (control) groups during the 5-year follow-up period. There is marked reduction in the mortality rate of patients enrolled in Ajwa group as compared to other group (RR=0.74; 95 % CI: 0.06-1.00). Furthermore, there was a significant reduction in the number of hospital admission per year in the Ajwa group (5.74Ã?±5.8 times) as compared to others (17.34Ã?±10.29 times), with a statistical significant difference (pâÂ?¤0.05). Additionally, the majority of patients on Ajwa group are currently off treatment. The main cause of death of patients in the non Ajwa group was disease progression and infections (76.9%). Ten patients with Acute Myeloid Leukemia in the Ajwa group (31.2%) showed protection against chemotherapy induced cardiac complications, while this didn't occur among the control group. Conclusions: Regular intake of Phoenix dactylifera (Ajwa) showed a significant decrease in the number of infections, number of hospitalization per year and mortality rate among pediatric cancer patients. Ajwa have some sort of cardiac protection. Adding Ajwa to the standard treatment of pediatric cancer patients can improve their treatment outcome.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Mar 2018
Effect of phoenix dactylifera palm fruit (Ajwa) on Infection, hospitalization, mortality and quality of life among pediatric cancer patients at single Medical Institute in Saudi Arabia
Conference abstract · 27 Jul 2015
Studies on genetic fidelity of cryopreserved calliof date palm cultivars (Phoenix dactylifera) from Saudi Arabia
Conference abstract · 22 Jun 2020
Outcome of the pediatric medulloblastoma patients: Single center experience from Saudi Arabia
Article · 28 Dec 2015
Implementation and Evaluation of Quality of Care for Pediatric Brain Tumor at a Single University Hospital in Saudi Arabia
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Positive outcome in a patient with hypoplastic left heart syndrome: Key factors for successful survival: A case report
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Soad K Al Jaouni”
- BylineArticles whose byline prints “Abear Hussein”
- BylineArticles whose byline prints “Nora Alghamdi”
- BylineArticles whose byline prints “Dalia Ezzat”
- BylineArticles whose byline prints “Steve Harakeh”
- BylineArticles whose byline prints “Nahla Khamis Ibrahim”
- BylineArticles whose byline prints “Rajaa Raddadi”
- BylineArticles whose byline prints “Shaker Mousa”

